Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12771706 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Condition: Breast Cancer
Intervention: Drug: Zometa

Study has passed its completion date and status has not been verified in more than two years.